-
Basel, March 31, 2022 — Novartis today announced that the European Commission (EC) has approved Beovu® (brolucizumab) 6 mg for the treatment of visual impairment due to diabetic macular edema (DME). Today’s approval in DME represents the second indication for Beovu granted by the EC, which was first approved for the treatment of wet age-related…OphthalmologyEye DisordersEye CareDiabetes
-
Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.Access to HealthcareEye CareEye DisordersOphthalmology
-
Eyesight initiatives are restoring vision – and hope – to thousands of people in Southeast Asia by expanding equitable access to eye care.
Access to HealthcareEye CareEye DisordersOphthalmologyPatient Voices -
Basel, October 29, 2020 — Novartis announced today that it has acquired Vedere Bio, adding a powerful new platform for AAV-based delivery of gene therapies and a best-in-class optogenetics program to help reimagine the treatment and prevention of vision loss and blindness. The acquisition builds on the company’s commitment in cell and gene therapy…Reimagine MedicineNew Scientific DiscoveriesEye Disorders
-
Basel, June 11, 2020 — Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Beovu® (brolucizumab) to include additional safety information regarding retinal vasculitis and retinal vascular occlusion1. This approval follows Novartis’ announcement that it would pursue worldwide label…OphthalmologyEye DisordersEye Care
-
Basel, July 27, 2020 — Novartis announced today results of a new post-hoc analysis of Beovu® (brolucizumab) Phase III HAWK and HARRIER pivotal trials demonstrating faster sustainable fluid control when compared with aflibercept in patients with wet age-related macular degeneration (wet AMD)1. Sustained dryness was defined as the beginning of three…Reimagine MedicineOphthalmologyEye Disorders
-
Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.
Children's HealthPatient VoicesRare DiseasesOphthalmologyEye Disorders -
Christine Hà lost her vision at a young age – and went on to become an award-winning chef.
Eye CareLiving With DiseaseEye Disorders -
Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.
Disease AwarenessEye CareLiving With DiseaseOphthalmologyEye Disorders -
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
Eye CareNovartis Institutes for BioMedical ResearchOphthalmologyEye Disorders -
Novartis taps MOOC technology to share chemistry education with the world
Drug DiscoveryNovartis Institutes for BioMedical ResearchTropical DiseasesClinical ResearchBiomedical JobsEye Disorders -
Biomedical ResearchNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesEye Disorders
Pagination
- 1
- 2
- › Next page